Drug intelligence / Profile preview

citric acid monohydrate

Development stage
Unknown
Lead developer
Bell's Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Bell's Simple Linctus is an over-the-counter (OTC) cough syrup manufactured by Bell's Healthcare, primarily used for the symptomatic relief of mild, non-specific acute coughs. Its active ingredient is citric acid monohydrate (125 mg per 5 ml for adults; 31.25 mg per 5 ml in the paediatric formulation), which functions as a demulcent. The drug works through a mechanical mechanism of action, forming a soothing, protective coating over the pharyngeal mucosa to reduce throat irritation and the sensory impulse to cough. It is a standard British Pharmacopoeia (BP) preparation and is frequently utilized as an active comparator in clinical research, such as the Phase 3 trial evaluating the antitussive CS1002. The product is available without a prescription and is generally indicated for adults and children over 12 years of age, though a paediatric formulation also exists.

Brand names
Bell's Simple LinctusBell's Simple Linctus BP
Other names
Simple LinctusBell's Simple Linctus

Beyond the preview

Go deeper on citric acid monohydrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on citric acid monohydrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call